Transkaryotic Therapies News
Most Popular Transkaryotic Therapies Story
Ex-Transkaryotic CEO settles SEC charges for $1.1M
Richard Selden, the former CEO of Transkaryotic Therapies, has agreed to pay more than $1.1 million to settle claims he misled investors and improperly pumped up the value of the company's stock by Read more...
Latest Headlines
- July 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
